DMK Pharmaceuticals Profit Margin

DMK Pharmaceuticals (DMKPQ) currently reports a profit margin of -91.28% as of September 2023. That compares with 803.94% in the prior-year period — down 111.4% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore DMK Pharmaceuticals's profit margin history and peer comparisons.

DMK Pharmaceuticals's profit margin decreased from 803.94% to -91.28% — a 111.4% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DMK Pharmaceuticals's profit margin of -91.28% is lower than the Healthcare sector average of 14.34%. That is roughly 736.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but DMK Pharmaceuticals's current -91.28% should be judged against Healthcare norms (sector average: 14.34%) and against DMKPQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -91.28%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for DMK Pharmaceuticals, and consider following DMKPQ for alerts when major investors trade the stock.